HK inno.N, Hits Upper Limit on U.S. Phase 3 Success[K-Bio Pulse]

• 김지완
• 2025.04.25
• 오전 07:42

How MFC Rose to the Top in the Crowded API Market[Yoo Sung’s Pharma National Wealth Theory]

• 류성
• 2025.04.24
• 오전 08:35

• Siilajen
• Vaxcell
• M2N

Sillajen Surge on FDA Nod, Patent Deal Vaxcell Bio Jumps[K-Bio Pulse]

• 송영두
• 2025.04.23
• 오전 07:40

Bridge Biotherapeutics Hits 5-Day Limit-Low; Sinsin Pharm and Psomagen Surge[K-Bio Pulse]

• 임정요
• 2025.04.22
• 오전 07:30

D&D Pharmatech·SG Healthcare Shares Surge on Hopes for New Drugs·USA Entry[K-bio Pulse]

• 신민준
• 2025.04.21
• 오전 07:31

• K-bioPulse
• InventageLab
• TiumBio
• BridgeBiot

Biotech Stocks Swing on Clinical Data; Inventage Lab, TiumBio Up[K-bio Pulse]

• 김새미
• 2025.04.18
• 오전 08:18

• CGMPharma
• SGHealthcare
• SynergyInnovation

Biotechs buck market slump; CMG Pharma among top gainers[K-Bio Pulse]

• 유진희
• 2025.04.17
• 오전 07:28

• BridgeBiotherapeutics
• Deepnoid
• YuYuPharma

Bridge Biotherapeutics Drops on Trial Miss; Deepnoid Rallies[K-bio Pulse]

• 김진수
• 2025.04.16
• 오전 07:30

• Daehwa
• Cytogen
• NIBEC

Daehwa Pharma stock hits year-high amid China sales optimism[K-Bio Pulse]

• 유진희
• 2025.04.15
• 오전 08:00

Peptron, Oncocross Hit Kosdaq Upper Limits as Obesity, AI Drug Themes Rally

• 임정요
• 2025.04.14
• 오전 07:35